phosphorylcholine has been researched along with Animal Mammary Carcinoma in 5 studies
Phosphorylcholine: Calcium and magnesium salts used therapeutically in hepatobiliary dysfunction.
phosphocholine : The phosphate of choline; and the parent compound of the phosphocholine family.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (20.00) | 18.2507 |
2000's | 2 (40.00) | 29.6817 |
2010's | 2 (40.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Li, X | 1 |
Zhao, Y | 1 |
Jiang, W | 1 |
Li, S | 1 |
Zhan, M | 1 |
Liu, H | 2 |
Zhang, C | 1 |
Liang, H | 1 |
Lu, L | 1 |
Wang, Y | 1 |
Guo, JP | 1 |
Coppola, D | 1 |
Cheng, JQ | 1 |
Duijsings, D | 1 |
Houweling, M | 1 |
Vaandrager, AB | 1 |
Mol, JA | 1 |
Teerds, KJ | 1 |
Whitehead, TL | 1 |
Monzavi-Karbassi, B | 1 |
Jousheghany, F | 1 |
Artaud, C | 1 |
Elbein, A | 1 |
Kieber-Emmons, T | 1 |
Spruss, T | 1 |
Bernhardt, G | 1 |
Schönenberger, H | 1 |
Engel, J | 1 |
5 other studies available for phosphorylcholine and Animal Mammary Carcinoma
Article | Year |
---|---|
Ultralong circulating choline phosphate liposomal nanomedicines for cascaded chemo-radiotherapy.
Topics: Animals; Anthraquinones; Antineoplastic Agents; Cell Hypoxia; Chemoradiotherapy; Female; Liposomes; | 2019 |
IKBKE protein activates Akt independent of phosphatidylinositol 3-kinase/PDK1/mTORC2 and the pleckstrin homology domain to sustain malignant transformation.
Topics: 3-Phosphoinositide-Dependent Protein Kinases; Animals; Breast Neoplasms; Cell Line, Tumor; Cell Tran | 2011 |
Hexadecylphosphocholine causes rapid cell death in canine mammary tumour cells.
Topics: Animals; Antineoplastic Agents; Cell Death; Cell Line, Tumor; CHO Cells; Cricetinae; Dogs; Dose-Resp | 2004 |
1H-NMR metabolic markers of malignancy correlate with spontaneous metastases in a murine mammary tumor model.
Topics: Animals; Antigens, Neoplasm; Biomarkers; Biomarkers, Tumor; Cell Adhesion; Cell Proliferation; Cell | 2005 |
Antitumour activity of miltefosine alone and after combination with platinum complexes on MXT mouse mammary carcinoma models.
Topics: Adenocarcinoma; Animals; Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Cisplatin; Drug | 1993 |